Covance site closure prompts sales push at Charles River
Charles River Laboratories is “aggressively” pursuing biopharma firms hit by the closure of Covance’s Arizona toxicology facility.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs